H1N1 Solomon Islands Protein

Catalog Number: orb425936

Catalog Number	orb425936
Category	Proteins
Description	H1N1 Solomon Islands protein
Form/Appearance	Sterile Filtered colorless solution.
Buffer/Preservatives	The H1N1 A/Solomon Islands/03/06 solution contains 0.1M NaCl, 10mM Tris-HCl, 1mM EDTA pH-8 (STE), 0.1% sodium azide (NaN3) and 0.005% thimerosal.
Purity	Greater than 90.0% as determined by SDS-PAGE.
Application notes	Inactivation: Thimerosal and beta propiolactone treatment.This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work. Immunological Activity: Tested with anti-influenza A monoclonal antibodies in ELISA.Serological studies of influenza A virus, immunogen for antibody production
Storage	Stability: A/Solomon Islands/03/06 although stable 4°C for 4 weeks, should be stored below -18°C. Please prevent freeze-thaw cycles
Note	For research use only

Purity:	> 97%, determined by SDS-PAGE
Source:	This protein contains the influenza A H1N1 (A/Solomon Islands/3/2006 (H1N1)) hemagglutinin (ABU991091) (Met 1-Gln 528, HA1+HA2, uncleved), was fused with a C-terminal polyhistidine tag and expressed from HEK293 Cells.

Sizes Available: 50 μg, 10 μg

Purity:	> 97%, determined by SDS-PAGE
Source:	This protein contains the N-terminal segment (Met 1-Arg 343) of the influenza A H1N1 hemagglutinin (A/Solomon Islands/3/2006 (H1N1)) (ABU991091), was fused with a C-terminal polyhistidine tag and expressed from HEK293 Cells.

Sizes Available: 100 μg, 50 μg

Purity:	98.00%
MW:	37.8 kDa (predicted); 50-60 kDa (reducing condition, due to glycosylation)

Purity:	97.60%
MW:	59 kDa (predicted); 60-70 kDa (reducing condition, due to glycosylation)